{"id":2422,"date":"2018-06-01T19:42:00","date_gmt":"2018-06-01T19:42:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2422"},"modified":"2025-01-15T03:14:09","modified_gmt":"2025-01-15T03:14:09","slug":"nonalcoholic-fatty-liver-disease-burden-saudi-arabia-and-united-arab-emirates-2017-2030","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/nonalcoholic-fatty-liver-disease-burden-saudi-arabia-and-united-arab-emirates-2017-2030\/","title":{"rendered":"Fardeau de la st\u00e9atose h\u00e9patique non alcoolique - Arabie saoudite et \u00c9mirats arabes unis, 2017-2030"},"content":{"rendered":"

R\u00e9sum\u00e9<\/h2>\n\n\n\n

Contexte \/ objectif<\/h3>\n\n\n\n

En raison des niveaux \u00e9pid\u00e9miques d'ob\u00e9sit\u00e9 et de diab\u00e8te sucr\u00e9 de type 2 (DM), la st\u00e9atose h\u00e9patique non alcoolique (NAFLD) et la st\u00e9atoh\u00e9patite non alcoolique (NASH) qui en r\u00e9sulte seront des facteurs d\u00e9terminants de la maladie du foie.
charge dans les ann\u00e9es \u00e0 venir en Arabie saoudite et aux \u00c9mirats arabes unis (EAU).<\/p>\n\n\n\n


Mat\u00e9riels et m\u00e9thodes<\/h3>\n\n\n\n

Des mod\u00e8les ont \u00e9t\u00e9 utilis\u00e9s pour estimer la progression de la maladie NAFLD et NASH, principalement sur la base des changements dans les taux de pr\u00e9valence chez les adultes de l'ob\u00e9sit\u00e9 et du diab\u00e8te chez les adultes. Les estimations publi\u00e9es et les entretiens d'experts ont \u00e9t\u00e9 utilis\u00e9s pour construire et valider les projections du mod\u00e8le.<\/p>\n\n\n\n


R\u00e9sultats<\/h3>\n\n\n\n

Dans les deux pays, la pr\u00e9valence de la NAFLD a augment\u00e9 jusqu'en 2030 parall\u00e8lement aux augmentations pr\u00e9vues de la pr\u00e9valence de l'ob\u00e9sit\u00e9 et du diab\u00e8te. En 2030, il y avait environ 12 534 000 cas de NAFLD en Arabie saoudite et 372 000 cas aux EAU. Les augmentations des cas de NASH \u00e9taient relativement plus importantes que les cas de NAFLD en raison du vieillissement de la population et de la progression de la maladie. De m\u00eame, les cas pr\u00e9valents de cirrhose compens\u00e9e et de maladie h\u00e9patique avanc\u00e9e devraient au moins doubler d'ici 2030, tandis que les d\u00e9c\u00e8s annuels accidentels du foie dans les deux pays atteignent 4800 d\u00e9c\u00e8s en Arabie saoudite et 140 d\u00e9c\u00e8s aux \u00c9mirats arabes unis.<\/p>\n\n\n\n


Conclusions<\/h3>\n\n\n\n

Les taux toujours \u00e9lev\u00e9s d'ob\u00e9sit\u00e9 et de diab\u00e8te chez les adultes, associ\u00e9s au vieillissement de la population, sugg\u00e8rent que les maladies h\u00e9patiques avanc\u00e9es et la mortalit\u00e9 attribuables \u00e0 la NAFLD \/ NASH augmenteront dans les deux pays. La r\u00e9duction de la croissance de la population NAFLD, ainsi que des options th\u00e9rapeutiques potentielles, seront n\u00e9cessaires pour r\u00e9duire le fardeau des maladies h\u00e9patiques.<\/p>\n\n\n\n

Des pays:<\/strong> Arabie saoudite, \u00c9mirats arabes unis<\/p>\n\n

\n
Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Summary Background\/Aim Due to epidemic levels of obesity and type 2 diabetes mellitus (DM), nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) will be driving factors in liver diseaseburden in the coming years in Saudi Arabia and United Arab Emirates (UAE). Materials and Methods Models were used to estimate NAFLD and NASH disease […]<\/p>\n","protected":false},"author":24,"featured_media":3468,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[24],"publication-author":[655,844,841,843,846,842,652,839,840,845,535,838,494,648],"class_list":["post-2422","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-nafld","publication-author-abaalkhail-f","publication-author-al-hamoudi-wk","publication-author-al-khathlan-a","publication-author-al-quraishi-h","publication-author-al-rifai-a","publication-author-al-zaabi-m","publication-author-alghamdi-m","publication-author-aljumah-aa","publication-author-alswat-k","publication-author-babatin-ma","publication-author-estes-c","publication-author-hashim-a","publication-author-razavi-h","publication-author-sanai-fm"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=2422"}],"version-history":[{"count":11,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2422\/revisions"}],"predecessor-version":[{"id":7538,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2422\/revisions\/7538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3468"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=2422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=2422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=2422"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=2422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}